GH Research GHRS
NASDAQ GHRS
$22.42 -0.44 (-1.92%)
As of: Oct 2, 2026 · 12:17 PM EDT

GH Research (GHRS) Beginning Cash Balance (2023 - 2026)

Updated

GH Research's Beginning Cash Balance came in at $246.25 million for Q1 2026, up 144.3% from $100.79 million a year earlier.

Analysis

GH Research (GHRS) Beginning Cash Balance (2023 - 2026) Analysis & Trends

Going back to Q1 2023, GH Research's Beginning Cash Balance data covers 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 GH Research 1.46 Bn 296.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 246.25 Mn
Mar 31, 2025 100.79 Mn
Mar 31, 2024 78.42 Mn
Mar 31, 2023 165.96 Mn
API Access

GH Research Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=GHRS&period=max&api_key=YOUR_API_KEY